Cleared Traditional

K022057 - KG MEDIX DISPOSABLE SYRING, 1,3,5,10, 20, 30, 50 ML'S,KG MEDIX

K022057 is an FDA 510(k) clearance for KG MEDIX DISPOSABLE SYRING, manufactured by Kyung GI Medical Ind. Co., Ltd.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 151-day FDA review.

K022057 · Kyung GI Medical Ind. Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2002
Decision
151d
Days
Class 2
Risk

K022057 is an FDA 510(k) clearance for the KG MEDIX DISPOSABLE SYRING, 1,3,5,10, 20, 30, 50 ML'S,KG MEDIX. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Kyung GI Medical Ind. Co., Ltd. (Kimpo-Si, Kyunggi-Do, KR). The FDA issued a Cleared decision on November 22, 2002 after a review of 151 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Kyung GI Medical Ind. Co., Ltd. devices

FDA 510(k) Submission Details - K022057

510(k) Number K022057 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 2002
Decision Date November 22, 2002
Days to Decision 151 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 129d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 430
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K022057.
TERUMO SURGUARD 2 SAFETY NEEDLE
K031453 · Terumo Medical Corp. · Jul 2003
MODIFICATION TO BD ULTRA-FINE III PEN NEEDLE
K031200 · Becton, Dickinson & CO · Jun 2003
BD ULTRA-FINE III PEN NEEDLE
K024109 · Becton, Dickinson & CO · Dec 2002
SURE-LOK
K021315 · Vital Signs, Inc. · Aug 2002
NIPRO HYPODERMIC NEEDLE
K013293 · Nipro Medical Corp. · Dec 2001
DISETRONIC PENFINE INSULIN INJECTION PEN NEEDLE
K013782 · Disetronic Medical Systems · Nov 2001